Literature DB >> 29185867

Change of olfactory function as a marker of inflammatory activity and disability progression in MS.

Gabriel Bsteh1, Harald Hegen1, Felix Ladstätter1, Klaus Berek1, Matthias Amprosi1, Sebastian Wurth1, Michael Auer1, Franziska Di Pauli1, Florian Deisenhammer1, Markus Reindl1, Thomas Berger1, Andreas Lutterotti2.   

Abstract

BACKGROUND: Impaired olfactory threshold has been reported in early inflammatory phases of MS, while impaired odor identification was associated with more widespread disability.
OBJECTIVE: To prospectively assess the development of olfactory function and its correlation with relapse and disability progression.
METHODS: In this prospective, 3-year longitudinal study on 151 MS patients and 30 healthy controls, three different qualities of olfactory function (threshold, discrimination, and identification) were quantified using the Sniffin' Sticks test. The influence of relapses and disability on olfactory function was analyzed at different time points and in a multivariate model.
RESULTS: Discrimination and identification capability significantly worsened over 3 years, while threshold did not. Threshold was markedly impaired in patients with relapse activity within 12 months, recovered in the absence of relapse, and was associated with a 2.5-fold increased risk of relapse. Deterioration of discrimination and identification was irreversible and both strongly associated with and predictive of EDSS progression.
CONCLUSION: Olfactory function changes over time in MS. Threshold impairment is transient and predicts inflammatory disease activity, while odor identification and discrimination are associated with disability progression. Olfactory dysfunction might be a useful and easily obtainable parameter to monitor patients with regard to inflammation and neurodegeneration in MS.

Entities:  

Keywords:  Multiple sclerosis; disability progression; discrimination; identification; olfactory threshold; relapse

Mesh:

Year:  2017        PMID: 29185867     DOI: 10.1177/1352458517745724

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  8 in total

1.  Neuronal Adenosine A1 Receptor is Critical for Olfactory Function but Unable to Attenuate Olfactory Dysfunction in Neuroinflammation.

Authors:  Charlotte Schubert; Kristina Schulz; Simone Träger; Anna-Lena Plath; Asina Omriouate; Sina C Rosenkranz; Fabio Morellini; Manuel A Friese; Daniela Hirnet
Journal:  Front Cell Neurosci       Date:  2022-06-30       Impact factor: 6.147

2.  Inner nuclear layer and olfactory threshold are interlinked and reflect inflammatory activity in multiple sclerosis.

Authors:  Gabriel Bsteh; Harald Hegen; Patrick Altmann; Klaus Berek; Michael Auer; Anne Zinganell; Franziska Di Pauli; Paulus Rommer; Fritz Leutmezer; Florian Deisenhammer; Thomas Berger
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-08-24

3.  Impairment of odor discrimination and identification is associated with disability progression and gray matter atrophy of the olfactory system in MS.

Authors:  Gabriel Bsteh; Ruth Steiger; Noora Tuovinen; Harald Hegen; Klaus Berek; Sebastian Wurth; Michael Auer; Franziska Di Pauli; Elke R Gizewski; Florian Deisenhammer; Thomas Berger; Christoph Scherfler
Journal:  Mult Scler       Date:  2019-03-21       Impact factor: 6.312

4.  Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis.

Authors:  Gabriel Bsteh; Klaus Berek; Harald Hegen; Arabella Buchmann; Margarete M Voortman; Michael Auer; Sebastian Wurth; Anne Zinganell; Franziska Di Pauli; Florian Deisenhammer; Micheal Khalil; Thomas Berger
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-11-05

5.  Prenatal Hypoxia Impairs Olfactory Function in Postnatal Ontogeny in Rats.

Authors:  N M Dubrovskaya; D S Vasilev; N L Tumanova; O S Alekseeva; N N Nalivaeva
Journal:  Neurosci Behav Physiol       Date:  2022-03-18

6.  Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis.

Authors:  Omid Mirmosayyeb; Narges Ebrahimi; Mahdi Barzegar; Alireza Afshari-Safavi; Sara Bagherieh; Vahid Shaygannejad
Journal:  PLoS One       Date:  2022-04-19       Impact factor: 3.240

7.  Smell as a Disease Marker in Multiple Sclerosis.

Authors:  Athanasia Printza; Marina Boziki; Constantinos Valsamidis; Christos Bakirtzis; Jannis Constantinidis; Nikolaos Grigoriadis; Stefanos Triaridis
Journal:  J Clin Med       Date:  2022-09-03       Impact factor: 4.964

8.  Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis.

Authors:  Tobias Monschein; Sabine Salhofer-Polanyi; Patrick Altmann; Tobias Zrzavy; Assunta Dal-Bianco; Gabriel Bsteh; Paulus Rommer; Thomas Berger; Fritz Leutmezer
Journal:  J Neurol       Date:  2020-09-14       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.